| Jun 3 |
Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?
|
| May 28 |
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
|
| May 15 |
Taysha Gene Therapies, Inc. (TSHA) Q1 2024 Earnings Call Transcript
|
| May 15 |
Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
| May 14 |
Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates
|
| May 14 |
Taysha Gene Therapies GAAP EPS of -$0.10 beats by $0.01, revenue of $3.41M beats by $0.85M
|
| May 14 |
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
| May 14 |
Taysha Gene Therapies upgraded at Jefferies on Rett Syndrome asset
|
| May 13 |
Taysha Gene Therapies Q1 2024 Earnings Preview
|
| May 7 |
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
|
